<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">67150</article-id><article-id pub-id-type="doi">10.7554/eLife.67150</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>RNA binding to human METTL3-METTL14 restricts <italic>N<sup>6</sup></italic>-deoxyadenosine methylation of DNA <italic>in vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author" id="author-225112"><name><surname>Qi</surname><given-names>Shan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0175-6267</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266378"><name><surname>Mota</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225114"><name><surname>Chan</surname><given-names>Siu-Hong</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-225115"><name><surname>Villarreal</surname><given-names>Johanna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225116"><name><surname>Dai</surname><given-names>Nan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-225117"><name><surname>Arya</surname><given-names>Shailee</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266379"><name><surname>Hromas</surname><given-names>Robert A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-266380"><name><surname>Rao</surname><given-names>Manjeet K</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-225118"><name><surname>Corrêa</surname><given-names>Ivan R</given-names><suffix>Jr</suffix></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3169-6878</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" corresp="yes" id="author-222480"><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6372-5007</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf6"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry and Structural Biology</institution>, <institution>The University of Texas Health Science Center at San Antonio</institution>, <addr-line><named-content content-type="city">San Antonio</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Greehey Children's Cancer Research Institute</institution>, <institution>The University of Texas Health Science Center at San Antonio</institution>, <addr-line><named-content content-type="city">San Antonio</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">RNA Biology</institution>, <institution>New England Biolabs</institution>, <addr-line><named-content content-type="city">Ipswich</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Medicine</institution>, <institution>The University of Texas Health Science Center at San Antonio</institution>, <addr-line><named-content content-type="city">San Antonio</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-105903"><name><surname>Haider</surname><given-names>Shozeb</given-names></name><role>Reviewing editor</role><aff><institution>University College London</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>guptay@uthscsa.edu</email> (YG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>01</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e67150</elocation-id><history><date date-type="received"><day>02</day><month>02</month><year>2021</year></date><date date-type="accepted"><day>20</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Qi et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Qi et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-67150-v1.pdf"/><abstract><p>Methyltransferase like-3 (METTL3) and METTL14 complex transfers a methyl group from <italic>S</italic>-adenosyl-L-methionine to <italic>N<sup>6</sup></italic> amino group of adenosine bases in RNA (m<sup>6</sup>A) and DNA (m<sup>6</sup>dA). Emerging evidence highlights a role of METTL3-METTL14 in the chromatin context, especially in processes where DNA and RNA are held in close proximity. However, a mechanistic framework about specificity for substrate RNA/DNA and their interrelationship remain unclear. By systematically studying methylation activity and binding affinity to a number of DNA and RNA oligos with different propensities to form inter- or intra-molecular duplexes or single-stranded molecules <italic>in vitro</italic>, we uncover an inverse relationship for substrate binding and methylation and show that METTL3-METTL14 preferentially catalyzes the formation of m<sup>6</sup>dA in single-stranded DNA (ssDNA), despite weaker binding affinity to DNA. In contrast, it binds structured RNAs with high affinity, but methylates the target adenosine in RNA (m<sup>6</sup>A) much less efficiently than it does in ssDNA. We also show that METTL3-METTL14-mediated methylation of DNA is largely restricted by structured RNA elements prevalent in long noncoding and other cellular RNAs.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006772</institution-id><institution>Max and Minnie Tomerlin Voelcker Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001325</institution-id><institution>San Antonio Area Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>IIMS/CTSA pilot award</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Greehey Children's Cancer Research Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Qi</surname><given-names>Shan</given-names></name><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007130</institution-id><institution>University of Texas System</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>1R01AI161363</award-id><principal-award-recipient><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Siu-Hong Chan, is an employee of New England Biolabs, a manufacturer and vendor of molecular biology reagents..</p></fn><fn fn-type="conflict" id="conf3"><p>Nan Dai, is an employee of New England Biolabs, a manufacturer and vendor of molecular biology reagents..</p></fn><fn fn-type="conflict" id="conf4"><p>Robert A Hromas, owns equity in Dialectic Therapeutics and Abfero..</p></fn><fn fn-type="conflict" id="conf5"><p>Ivan R Corrêa, is an employee of New England Biolabs, a manufacturer and vendor of molecular biology reagents..</p></fn><fn fn-type="conflict" id="conf6"><p>Yogesh K Gupta, is founder of Atomic Therapeutics. None of these affiliations affect the authors' impartiality, adherence to journal standards and policies, or availability of data..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The information about coding sequences of human METTL3 (NCBI reference sequence GI: 33301371) and METTL14 (NCBI reference sequence GI: 172045930) used in this study is available at NCBI. Source data are provided as a separate Source Data file. Correspondence and requests for material should be addressed to Y.K.G. (guptay@uthscsa.edu).</p></sec><supplementary-material><ext-link xlink:href="elife-67150-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>